Balanced news tone
News Sentiment
GERN sentiment intelligence
Geron Corporation news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Price is moving more forcefully than the current news tone suggests.
83/100 classification confidence.
directly relevant articles
high-authority source matches
+10.3% over one week, +30.4% over four weeks, trend inactive, and below fair value.
Geron (GERN) Is Signaling Commercial Ambition, Not Just Handing Out Options
Market Reaction
Price moving ahead of tone
Price is moving more forcefully than the current news tone suggests.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
Geron plans Goldman Sachs healthcare fireside chat, webcast June 8
Geron (Nasdaq: GERN) announced its participation in the Goldman Sachs 47th Annual Global Healthcare Conference, where company management will host a fireside chat on Monday, June 8, 2026, at 8:40 a.m. ET in Miami, Florida. A live and archived audio webcast of the event will be av
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 01 Jun 2026 12:09
- Source
- Stock Titan
Geron: Time To Reconsider This Oversold Biotech (NASDAQ:GERN)
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 01 Jun 2026 07:00
- Source
- Seeking Alpha
GERN - Aging Population Trends Will Expand Hematology Market Opportunity
Analysts have slightly revised down Geron's price target due to more conservative assumptions regarding revenue growth, profit margins, and future P/E, though the intrinsic fair value estimate remains unchanged. Bullish analysts see this as a fine-tuning, while bearish analysts v
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 27 May 2026 22:40
- Source
- Simply Wall Street
Geron (NASDAQ: GERN) director awarded stock options for 220,000 shares at $1.26
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 26 May 2026 07:00
- Source
- Stock Titan
Geron (GERN) Loses 21.2% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 19 May 2026 07:00
- Source
- Market source
Five new Geron hires receive options for 333,750 shares
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 18 May 2026 07:00
- Source
- Stock Titan
There May Be Reason For Hope In Puma Biotechnology's (NASDAQ:PBYI) Disappointing Earnings
- Tone
- Negative 34/100
- Event
- Earnings
- Published
- 15 May 2026 07:00
- Source
- simplywall.st
Puma Biotechnology's (NASDAQ:PBYI) Conservative Accounting Might Explain Soft Earnings
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 14 May 2026 07:00
- Source
- Market source
Geron (GERN) to Present New Study Findings at EHA 2026 Congress
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 12 May 2026 07:00
- Source
- GuruFocus
Is Geron (GERN) One of the Best US Stocks Under $5 to Buy?
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 11 May 2026 07:00
- Source
- Market source
Puma Biotechnology, Inc. (NASDAQ:PBYI) Analysts Are Pretty Bullish On The Stock After Recent Results
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 11 May 2026 07:00
- Source
- simplywall.st
Earnings Update: Here's Why Analysts Just Lifted Their Puma Biotechnology, Inc. (NASDAQ:PBYI) Price Target To US$5.00
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 11 May 2026 07:00
- Source
- Market source
Assessing Geron (GERN) Valuation After Q1 2026 Earnings Beat And RYTELO Growth Progress
- Tone
- Positive 82/100
- Event
- Earnings
- Published
- 09 May 2026 07:00
- Source
- simplywall.st
Geron Corporation (NASDAQ:GERN) Just Reported And Analysts Have Been Lifting Their Price Targets
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 08 May 2026 07:00
- Source
- Market source
A Look At Geron (GERN) Valuation After Q1 Results And Reaffirmed 2026 Guidance
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 08 May 2026 07:00
- Source
- Market source
Can Geron’s (GERN) Narrowing Losses Reframe Expectations For Its Blood Cancer Earnings Potential?
- Tone
- Negative 34/100
- Event
- Earnings
- Published
- 08 May 2026 07:00
- Source
- simplywall.st
Geron (GERN) Q1 Loss Sharply Narrows And Tests Skeptical Profitability Narratives
- Tone
- Negative 34/100
- Event
- Market update
- Published
- 07 May 2026 07:00
- Source
- simplywall.st
Geron (GERN) Reports Q1 Loss, Beats Revenue Estimates
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 06 May 2026 07:00
- Source
- Market source
Q4 Earnings Highlights: Regeneron (NASDAQ:REGN) Vs The Rest Of The Biotechnology Stocks
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 25 Apr 2026 07:00
- Source
- Market source
Biotechnology Stocks Q3 Results: Benchmarking Natera (NASDAQ:NTRA)
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 21 Apr 2026 07:00
- Source
- Market source
Geron Adds Chief Legal Officer As Equity Incentives And Valuation Draw Focus
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 16 Apr 2026 07:00
- Source
- simplywall.st
New Geron legal chief gets option to buy 2.5M shares at $1.73
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 14 Apr 2026 07:00
- Source
- Stock Titan
Geron Highlights RYTELO Launch, 2026 Revenue Outlook and Phase 3 Myelofibrosis Plans at Needham Conf
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 13 Apr 2026 07:00
- Source
- Market source
A Look Back at Biotechnology Stocks’ Q4 Earnings: Incyte (NASDAQ:INCY) Vs The Rest Of The Pack
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 29 Mar 2026 07:00
- Source
- TradingView
Is Geron (GERN) Pricing Look Attractive After Recent Share Price Rebound?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 24 Feb 2026 08:00
- Source
- Market source
Geron (GERN) Sets 2026 Financial Goals, TD Cowen Cuts PT
- Tone
- Negative 34/100
- Event
- Market update
- Published
- 23 Feb 2026 08:00
- Source
- Market source
Geron Corporation's (NASDAQ:GERN) Prospects Need A Boost To Lift Shares
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 03 Feb 2026 08:00
- Source
- simplywall.st
Geron: Rytelo Launch Stalls Out, EU Partnership And IMpactMF Results Could Help (GERN)
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 07 Nov 2025 08:00
- Source
- Seeking Alpha